サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1781182

獣医循環器学の世界市場、動物の種類別、製品別、適応症別、エンドユーザー別、流通チャネル別、地域別、機会、予測、2018年～2032年

Global Veterinary Cardiology Market Assessment, By Animal Type, By Product, By Indication, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2018-2032F

出版日
ページ情報
英文 233 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.46円
獣医循環器学の世界市場、動物の種類別、製品別、適応症別、エンドユーザー別、流通チャネル別、地域別、機会、予測、2018年～2032年
出版日: 2025年08月01日
発行: Markets & Data
ページ情報: 英文 233 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の獣医循環器学市場は、予測期間2025-2032年にCAGR 7.21%を記録し、2024年の30億2,000万米ドルから2032年には52億7,000万米ドルに成長すると予測されています。獣医循環器学の世界市場は成長を続けており、その主な要因は、ペットの飼育数の増加、動物の心臓の健康に対する意識の高まり、高度な診断・治療オプションに対する需要の高まりです。コンパニオンアニマルが長生きするようになり、飼い主がペットの幸福をより重視するようになるにつれて、心臓画像診断、モニタリング、治療介入などの専門的サービスの必要性が高まっています。

携帯型心電図装置、遠隔心電図検査、侵襲性の低い手技などの技術の進歩は、獣医の心臓治療の利用しやすさと精度の向上に役立っています。獣医のインフラ、ペット保険の適用範囲、ペット支出の増加も市場の成長をさらに後押ししています。市場環境は、北米が最大の市場シェアを占め、アジア太平洋がペットの飼育増加と獣医学的ケアの向上により最大かつ最速の成長市場となっており、今後も堅調に推移すると予想されます。市場が直面する2つの大きな課題は、高い機器と運用コスト、訓練された獣医放射線技師に関する限られた人的資源、地域によって断片的で一貫性のない規制経路です。さらに、犬の心臓疾患、特に拡張型心筋症や僧帽弁疾患の継続的な発生は、心臓病学サービスに対する需要を高めています。

例えば、タフツ大学カミングス獣医学部の2024年9月の報告によると、獣医師が診察した動物の10％以上に心臓血管疾患の兆候が見られます。これらの疾患は時間とともに悪化する傾向があり、早期発見が困難な場合が多いことから、獣医循環器学市場における正確な診断ツールと長期的な薬物治療の必要性が高まっていることが浮き彫りになっています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 世界の獣医循環器学市場の展望、2018年～2032年

  • 市場規模分析と予測
    • 金額別
  • 市場シェア分析と予測
    • 動物の種類別
      • コンパニオンアニマル
      • 家畜
    • 製品別
      • 医薬品
      • 診断
    • 適応症別
      • うっ血性心不全
      • 心筋疾患
      • 不整脈
      • その他
    • エンドユーザー別
      • 動物病院と診療所
      • 学術調査機関
      • その他
    • 流通チャネル別
      • 病院薬局
      • 小売薬局
      • eコマース
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • 南米
      • 中東およびアフリカ
    • 企業別市場シェア分析（上位5社およびその他- 金額別、2024年）
  • 2024年市場マップ分析
    • 動物の種類別
    • 製品別
    • 適応症別
    • エンドユーザー別
    • 流通チャネル別
    • 地域別

第6章 北米の獣医循環器学市場の展望、2018年～2032年

  • 市場規模分析と予測
    • 金額別
  • 市場シェア分析と予測
    • 動物の種類別
      • コンパニオンアニマル
      • 家畜
    • 製品別
      • 医薬品
      • 診断
    • 適応症別
      • うっ血性心不全
      • 心筋疾患
      • 不整脈
      • その他
    • エンドユーザー別
      • 動物病院と診療所
      • 学術調査機関
      • その他
    • 流通チャネル別
      • 病院薬局
      • 小売薬局
      • eコマース
    • 国別シェア
      • 米国
      • カナダ
      • メキシコ
  • 国別市場評価
    • 米国の獣医循環器学市場の展望、2018年～2032年予測
      • 市場規模分析と予測
      • 市場シェア分析と予測
    • カナダ
    • メキシコ

すべてのセグメントは、対象となるすべての地域と国に提供されます。

第7章 欧州の獣医循環器学市場の展望、2018年～2032年

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド

第8章 アジア太平洋の獣医循環器学市場の展望、2018年～2032年

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第9章 南米の獣医循環器学市場の展望、2018年～2032年

  • ブラジル
  • アルゼンチン

第10章 中東・アフリカの獣医循環器学市場の展望、2018年～2032年

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

  • 市場促進要因
  • 市場の課題

第16章 市場動向と発展

第17章 臨床試験の情勢

第18章 規制枠組みとイノベーション

第19章 ケーススタディ

第20章 競合情勢

  • 市場リーダー上位5社の競合マトリックス
  • トップ5企業のSWOT分析
  • 市場トップ10の主要企業の情勢
    • Dextronix, Inc
      • 会社概要
      • 主要経営陣
      • 製品とサービス
      • 財務状況（報告通り）
      • 主要市場への注力と地理的プレゼンス
      • 最近の動向/コラボレーション/ パートナーシップ/ 合併と買収
    • IDEXX Laboratories, Inc.
    • Contec Medical Systems Co. Ltd
    • Antech Diagnostics, Inc.
    • Bionet Co., Ltd
    • Eickemeyer Veterinary Equipment Limited
    • Narang Medical Limited
    • Shenzhen Comen Medical Instruments Co., Ltd
    • iWorx Systems Inc
    • New Gen Medical Systems Inc.

上記の企業は市場シェアに応じて注文を保留するものではなく、調査作業中に入手可能な情報に応じて変更される可能性があります。

第21章 戦略的提言

第22章 調査会社について・免責事項

図表

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 3. Global Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 4. Global Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 5. Global Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 6. Global Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 7. Global Veterinary Cardiology Market Share (%), By Region, 2018-2032F
  • Figure 8. North America Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 9. North America Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 10. North America Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 11. North America Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 12. North America Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 13. North America Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 14. North America Veterinary Cardiology Market Share (%), By Country, 2018-2032F
  • Figure 15. United States Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. United States Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 17. United States Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 18. United States Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 19. United States Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 20. United States Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 21. Canada Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 22. Canada Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 23. Canada Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 24. Canada Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 25. Canada Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 26. Canada Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 27. Mexico Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 28. Mexico Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 29. Mexico Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 30. Mexico Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 31. Mexico Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 32. Mexico Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 33. Europe Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 34. Europe Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 35. Europe Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 36. Europe Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 37. Europe Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 38. Europe Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 39. Europe Veterinary Cardiology Market Share (%), By Country, 2018-2032F
  • Figure 40. Germany Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. Germany Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 42. Germany Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 43. Germany Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 44. Germany Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 45. Germany Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 46. France Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 47. France Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 48. France Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 49. France Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 50. France Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 51. France Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 52. Italy Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Italy Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 54. Italy Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 55. Italy Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 56. Italy Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 57. Italy Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 58. United Kingdom Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 59. United Kingdom Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 60. United Kingdom Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 61. United Kingdom Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 62. United Kingdom Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 63. United Kingdom Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 64. Russia Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Russia Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 66. Russia Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 67. Russia Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 68. Russia Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 69. Russia Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 70. Netherlands Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 71. Netherlands Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 72. Netherlands Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 73. Netherlands Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 74. Netherlands Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 75. Netherlands Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 76. Spain Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 77. Spain Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 78. Spain Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 79. Spain Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 80. Spain Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 81. Spain Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 82. Turkey Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. Turkey Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 84. Turkey Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 85. Turkey Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 86. Turkey Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 87. Turkey Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 88. Poland Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 89. Poland Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 90. Poland Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 91. Poland Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 92. Poland Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 93. Poland Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 94. Asia-Pacific Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Asia-Pacific Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 96. Asia-Pacific Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 97. Asia-Pacific Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 98. Asia-Pacific Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 99. Asia-Pacific Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 100. Asia-Pacific Veterinary Cardiology Market Share (%), By Country, 2018-2032F
  • Figure 101. India Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 103. India Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 104. India Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 105. India Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 106. India Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 107. China Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 108. China Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 109. China Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 110. China Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 111. China Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 112. China Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 113. Japan Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 114. Japan Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 115. Japan Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 116. Japan Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 117. Japan Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 118. Japan Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 119. Australia Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Australia Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 121. Australia Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 122. Australia Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 123. Australia Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 124. Australia Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 125. Vietnam Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 126. Vietnam Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 127. Vietnam Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 128. Vietnam Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 129. Vietnam Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 130. Vietnam Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 131. South Korea Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. South Korea Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 133. South Korea Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 134. South Korea Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 135. South Korea Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 136. South Korea Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 137. Indonesia Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 138. Indonesia Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 139. Indonesia Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 140. Indonesia Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 141. Indonesia Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 142. Indonesia Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 143. Philippines Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 144. Philippines Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 145. Philippines Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 146. Philippines Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 147. Philippines Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 148. Philippines Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 149. South America Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 150. South America Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 151. South America Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 152. South America Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 153. South America Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 154. South America Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 155. South America Veterinary Cardiology Market Share (%), By Country, 2018-2032F
  • Figure 156. Brazil Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 157. Brazil Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 158. Brazil Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 159. Brazil Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 160. Brazil Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 161. Brazil Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 162. Argentina Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 163. Argentina Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 164. Argentina Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 165. Argentina Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 166. Argentina Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 167. Argentina Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 168. Middle East & Africa Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 169. Middle East & Africa Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 170. Middle East & Africa Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 171. Middle East & Africa Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 172. Middle East & Africa Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 173. Middle East & Africa Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 174. Middle East & Africa Veterinary Cardiology Market Share (%), By Country, 2018-2032F
  • Figure 175. Saudi Arabia Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 176. Saudi Arabia Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 177. Saudi Arabia Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 178. Saudi Arabia Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 179. Saudi Arabia Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 180. Saudi Arabia Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 181. UAE Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 182. UAE Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 183. UAE Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 184. UAE Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 185. UAE Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 186. UAE Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 187. South Africa Veterinary Cardiology Market, By Value, In USD Billion, 2018-2032F
  • Figure 188. South Africa Veterinary Cardiology Market Share (%), By Animal Type, 2018-2032F
  • Figure 189. South Africa Veterinary Cardiology Market Share (%), By Product, 2018-2032F
  • Figure 190. South Africa Veterinary Cardiology Market Share (%), By Indication, 2018-2032F
  • Figure 191. South Africa Veterinary Cardiology Market Share (%), By End-user, 2018-2032F
  • Figure 192. South Africa Veterinary Cardiology Market Share (%), By Distribution Channel, 2018-2032F
  • Figure 193. By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 194. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 195. By Indication Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 197. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 198. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX13840

Global veterinary cardiology market is projected to witness a CAGR of 7.21% during the forecast period 2025-2032, growing from USD 3.02 billion in 2024 to USD 5.27 billion in 2032. The global market for veterinary cardiology continues to grow, mainly fueled by rising pet ownership, increased awareness of animal heart health, and the growing demand for advanced diagnostic and treatment options. As companion animals live longer and pet owners become more invested in their pets' well-being, the need for specialized services such as cardiac imaging, monitoring, and therapeutic interventions is increasing.

Increases in technology, such as portable ECG devices, tele-cardiology and procedures that are less invasive in nature, are helping to increase the accessibility and accuracy of veterinary based cardiac care. Increases in veterinary infrastructure, pet insurance coverage and pet expenditures are also bolstering growth in the market further. The market environment is expected to remain strong going forward with North America having the largest market share and Asia-Pacific becoming the largest and fastest growing market as a result of increased pet adoption and improved veterinary care. The two biggest challenges facing the market are high equipment and operational costs, limited human resources pertaining to trained veterinary radiologists, and fragmented and inconsistent regulatory pathways in different regions. In addition, the continued incidence of heart conditions in dogs, specifically dilated cardiomyopathy and mitral valve disease, increases demand for cardiology services.

For instance, according to a September 2024 report from Tufts University, Cummings School of Veterinary Medicine, over 10% of animals examined by veterinarians show signs of cardiovascular disease. These conditions tend to worsen over time and are often difficult to detect in early stages, which highlights the increasing need for accurate diagnostic tools and long-term pharmaceutical treatment in the veterinary cardiology market.

Technological Advancement Driving Growth in the Veterinary Cardiology Market

Technological advancements are having a big impact on the expansion of the veterinary cardiology market. Recent advancements in veterinary cardiology includes the development of digital electrocardiograms (ECGs), high-resolution imaging systems, and portable ultrasound and diagnostic devices. These technological advancements have considerably improved the rate and accuracy of a cardiac assessment in the animal population. It has enabled veterinary professionals to diagnose chronic degenerative heart disease earlier and treat the heart condition quickly and accurately. Telemedicine is also contributing to this trend by providing remote access to veterinary cardiology specialists by regions that often can't provide access to channel veterinary cardiology services. The availability of user-friendly pet-specific medical devices is contributing to compliance and monitoring in treatment of pets with cardiac disease. As technology has continued to improve, it is making cardiac care more accessible, precise, efficient, and affordable and thus opening the door to greater demand worldwide and new skill sets for veterinary cardiology practices.

For instance, in September 2024, the Atlantic Veterinary College at the University of Prince Edward Island launched a clinical trial to treat cardiac tumors in dogs. The study explores the use of propranolol, a drug commonly used for similar conditions in children, marking a step forward in veterinary cardiac oncology. In another instance, in February 2025, Golden Hour launched STAT telemedicine Services for the veterinary industry. This service aims to improve access to real-time cardiology consultations, especially in areas with limited specialist availability.

Rising Pet Ownership Driving Adoption in Veterinary Cardiology Market

Rising levels of pet ownership in combination with the increasing humanization of companion animals will continue to affect the growth of the veterinary cardiology market. More households are adopting pets and seeing them as a family member. With this humanization of pets comes higher expectations around the veterinary care that pets receive, which has evolved into more advanced and specialized care, including cardiac diagnostics and treatment. This emotional bond is resulting in increased healthcare spending, as pet owners are becoming more proactive in seeking preventive care and paying attention to symptoms of heart-related diseases. The rise in pet adoption and pet owners, especially the younger generations has also expanded the total addressable market for pet services. Therefore, opportunities are consistently creating demand for cardiology solutions within veterinary practices, and driving clinics to invest in equipment, who perform cardiology, expertise, and innovative cardiovascular technologies to accommodate evolving pet parent consumer expectations.

For instance, data from the 2024 American Veterinary Medical Association (AVMA) Pet Ownership and Demographic Sourcebook revealed that 45.5% of United States households own dogs and 32.1% own cats, totaling approximately 89.7 million dogs and 73.8 million cats nationwide.

Pharmaceuticals Segment Dominates the Veterinary Cardiology Market

The pharmaceuticals segment plays a key role in the veterinary cardiology market. It includes drugs like pimobendan, spironolactone, and benazepril. These medicines help manage heart failure and other heart conditions in pets. They improve heart function and reduce symptoms. Most are easy to give and work well for long-term use. Pet owners are now more aware of early treatment options. This increases demand for heart medications. Clinics use these drugs regularly for cardiac care. New formulations, like oral solutions, are also being developed. These innovations support better dosing and compliance. As heart issues in pets rise, this segment will likely keep growing.

For instance, in April 2024, the U.S. Food and Drug Administration (FDA) approved the first generic version of pimobendan for managing congestive heart failure in dogs. This approval is expected to improve accessibility and reduce treatment costs, offering veterinarians and pet owners a more affordable option for long-term cardiac care.

North America Dominates the Market

North America maintains a leading position in the global veterinary cardiology market due to its advanced veterinary healthcare infrastructure, high standards of clinical practice, and strong demand for specialized services. The reason behind the dominance of this region is high percentage of pet ownership, increased awareness of cardiovascular diseases in their companion animals, and pet owners are generally more willing to invest in advanced veterinary care. North America has major corporate players, established diagnostic networks, and keen interest in innovative technologies advances impacting the field of veterinary cardiology, in particular imaging and ECG and telemedicine. Furthermore, robust regulatory policies, an ample supply of veterinary specialists, and ongoing investment in research and development are also unique characteristics of North America with both being positive indicators for continued veterinary cardiology growth and innovation. All of these factors synergistically contribute to North America being able to continue advancing the industry as well as continue to spur global trends and directions in veterinary cardiology.

For instance, in November 2024, Boehringer Ingelheim Vetmedica GmbH launched VETMEDIN Solution, the first FDA-approved oral solution for treating congestive heart failure in dogs. This new formulation allows for easier dosing and improved treatment compliance. Its introduction aligns with rising demand for advanced cardiac care in emerging veterinary markets.

Impact of U.S. Tariffs on Veterinary Cardiology Market

U.S. tariffs continue to affect the veterinary cardiology market. Import duties on medical devices and components drive up clinic expenses. Products like stethoscopes, monitors, and imaging systems are harder to afford. Clinics may reduce the frequency of cardiac screenings. Some avoid purchasing new equipment altogether. This slows down adoption of new technologies.

Clients may face higher fees for advanced diagnostics. Smaller practices feel the strain most. Their limited budgets make it harder to absorb rising costs. To adapt, many clinics seek cost-effective or refurbished devices. Others are renegotiating supplier contracts. Some turn to bulk purchasing or group buying networks. These steps help manage expenses without compromising care quality. However, the long-term impact may limit innovation and accessibility in veterinary cardiology across the globe.

Key Players Landscape and Outlook

Key players in the global veterinary cardiology market are focusing on innovation to stay competitive. IDEXX Laboratories, Inc.., Dextronix, Inc., and Antech Diagnostics, Inc. are incorporating artificial intelligence, cloud computing ECG systems, and wireless telemetry into their offerings. Bionet Co., Ltd. Contec Medical Systems Co., Ltd., and Shenzhen Comen Medical Instruments Co., Ltd. are working on portable and cost-effective cardiac monitors. These monitors are very useful for large-hospital settings and small clinics. Eickemeyer Veterinary Equipment Limited, Narang Medical Limited, iWorx Systems Inc., and New Gen Medical Systems Inc. are enhancing their products through ongoing research and development. Many of the firms are pursuing partnerships with veterinary clinics, universities, and other research institutions increase the discoveries they make and hopes of improving diagnostic accuracy or treatment outcomes. Innovation, accessibility, and reaching more countries are centered around tackling advancement in animal cardiac services to meet increasing requests for these services.

For instance, in June 2025, Boehringer Ingelheim Vetmedica GmbH and Eko Health Inc. partnered to improve heart murmur detection in dogs. The collaboration uses Eko's AI-enabled stethoscope technology to help vets detect cardiac issues earlier and more accurately during routine exams.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Veterinary Cardiology Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Animal Type
      • 5.2.1.1. Companion Animals
      • 5.2.1.2. Livestock Animals
    • 5.2.2. By Product
      • 5.2.2.1. Pharmaceuticals
      • 5.2.2.2. Diagnostics
    • 5.2.3. By Indication
      • 5.2.3.1. Congestive Heart Failure
      • 5.2.3.2. Myocardial (Heart Muscle) Disease
      • 5.2.3.3. Arrhythmias
      • 5.2.3.4. Others
    • 5.2.4. By End-user
      • 5.2.4.1. Veterinary Hospitals and Clinics
      • 5.2.4.2. Academic and Research Institutions
      • 5.2.4.3. Others
    • 5.2.5. By Distribution Channel
      • 5.2.5.1. Hospital Pharmacy
      • 5.2.5.2. Retail Pharmacy
      • 5.2.5.3. E-Commerce
    • 5.2.6. By Region
      • 5.2.6.1. North America
      • 5.2.6.2. Europe
      • 5.2.6.3. Asia-Pacific
      • 5.2.6.4. South America
      • 5.2.6.5. Middle East and Africa
    • 5.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Animal Type
    • 5.3.2. By Product
    • 5.3.3. By Indication
    • 5.3.4. By End-user
    • 5.3.5. By Distribution Channel
    • 5.3.6. By Region

6. North America Veterinary Cardiology Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Animal Type
      • 6.2.1.1. Companion Animals
      • 6.2.1.2. Livestock Animals
    • 6.2.2. By Product
      • 6.2.2.1. Pharmaceuticals
      • 6.2.2.2. Diagnostics
    • 6.2.3. By Indication
      • 6.2.3.1. Congestive Heart Failure
      • 6.2.3.2. Myocardial (Heart Muscle) Disease
      • 6.2.3.3. Arrhythmias
      • 6.2.3.4. Others
    • 6.2.4. By End-user
      • 6.2.4.1. Veterinary Hospitals and Clinics
      • 6.2.4.2. Academic and Research Institutions
      • 6.2.4.3. Others
    • 6.2.5. By Distribution Channel
      • 6.2.5.1. Hospital Pharmacy
      • 6.2.5.2. Retail Pharmacy
      • 6.2.5.3. E-Commerce
    • 6.2.6. By Country Share
      • 6.2.6.1. United States
      • 6.2.6.2. Canada
      • 6.2.6.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Veterinary Cardiology Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Animal Type
          • 6.3.1.2.1.1. Companion Animals
          • 6.3.1.2.1.2. Livestock Animals
        • 6.3.1.2.2. By Product
          • 6.3.1.2.2.1. Pharmaceuticals
          • 6.3.1.2.2.2. Diagnostics
        • 6.3.1.2.3. By Indication
          • 6.3.1.2.3.1. Congestive Heart Failure
          • 6.3.1.2.3.2. Myocardial (Heart Muscle) Disease
          • 6.3.1.2.3.3. Arrhythmias
          • 6.3.1.2.3.4. Others
        • 6.3.1.2.4. By End-user
          • 6.3.1.2.4.1. Veterinary Hospitals and Clinics
          • 6.3.1.2.4.2. Academic and Research Institutions
          • 6.3.1.2.4.3. Others
        • 6.3.1.2.5. By Distribution Channel
          • 6.3.1.2.5.1. Hospital Pharmacy
          • 6.3.1.2.5.2. Retail Pharmacy
          • 6.3.1.2.5.3. E-Commerce
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Veterinary Cardiology Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Veterinary Cardiology Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Veterinary Cardiology Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Veterinary Cardiology Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

  • 15.1. Market Drivers
  • 15.2. Market Challenges

16. Market Trends and Developments

17. Clinical Trial Landscape

18. Regulatory Framework and Innovation

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Dextronix, Inc
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 20.3.2. IDEXX Laboratories, Inc.
    • 20.3.3. Contec Medical Systems Co. Ltd
    • 20.3.4. Antech Diagnostics, Inc.
    • 20.3.5. Bionet Co., Ltd
    • 20.3.6. Eickemeyer Veterinary Equipment Limited
    • 20.3.7. Narang Medical Limited
    • 20.3.8. Shenzhen Comen Medical Instruments Co., Ltd
    • 20.3.9. iWorx Systems Inc
    • 20.3.10. New Gen Medical Systems Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer